Optimizing enfortumab vedotin plus pembrolizumab therapy (IMAGE)

Impact Journals LLC

Optimizing enfortumab vedotin plus pembrolizumab therapy

Caption

Figure 1: Bladder cancer progression. Genetic alterations, signaling pathways, and targeted therapies; Created in BioRender. Prince, G. (2025) https://BioRender.com/r59h797.

Credit

Copyright: © 2025 Karam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Usage Restrictions

With credit to the original source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.